Yonsei Med J.  2007 Dec;48(6):1061-1065. 10.3349/ymj.2007.48.6.1061.

Synchronous Adenocarcinoma and Mantle Cell Lymphoma of the Stomach

Affiliations
  • 1Department of Surgery, Ewha Womans University College of Medicine, Seoul, Korea. kimyi@ewha.ac.kr

Abstract

Synchronous occurrence of mantle cell lymphoma (MCL) and gastric cancer in the same patient has not yet been reported in the English literature. MCL comprises 2.5-7% of non-Hodgkin's lymphomas and is characterized by a poor prognosis with a median survival probability of 3-4 years in most series. A 62-year-old man was referred to our hospital for evaluation of an abnormal gastric lesion. The endoscopic finding was compatible with type IIc early gastric cancer (EGC) in the middle third of the stomach, and a biopsy of the lesion proved to be carcinoma. Radical total gastrectomy with splenectomy and Roux-en-Y esophagojejunostomy were performed. The resected specimen revealed two grossly separated lesions. Postoperative histological examination reported both adenocarcinoma and MCL. Immunohistochemical staining showed positivity for CD5, CD20, and cyclin D1 in the infiltrated lymphoid cells. MCL is an aggressive non-Hodgkin's lymphoma, and the current treatment approach is still unsatisfactory. Further advancements in the understanding of the synchronous occurrence of both diseases, and more efforts on investigations of treatment are needed.

Keyword

Synchronous; adenocarcinoma; mantle cell lymphoma

MeSH Terms

Adenocarcinoma/complications/metabolism/*pathology
Antigens, CD20/analysis
Antigens, CD5/analysis
Cyclin D1/analysis
Humans
Immunohistochemistry
Lymphoma, Mantle-Cell/complications/metabolism/*pathology
Male
Middle Aged
Stomach/chemistry/*pathology
Stomach Neoplasms/complications/metabolism/*pathology

Figure

  • Fig. 1 Endoscopic images of the stomach showing two mucosal abnormalities on the lesser and greater curvatures.

  • Fig. 2 Gross findings of the resected stomach and its histological mapping.

  • Fig. 3 The stomach shows well differentiated adenocarcinoma at the superficial portion of the mucosa (× 40, Hematoxylin & Eosin (H&E) stain).

  • Fig. 4 Multiple, round lymphoid aggregates are noted in the mucosa and submucosa (× 10, H&E stain).

  • Fig. 5 The lymphocytes are small and monotonous (H&E, × 200), which are positive for CD20, CD5, and cyclin-D1 (× 400). These findings are consistent with the diagnosis of mantle cell lymphoma.


Reference

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997. 89:3909–3918.
2. Lenz G, Dreyling M, Hiddemann W. Mantle cell lymphoma: established therapeutic options and future directions. Ann Hematol. 2004. 83:71–77.
3. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group Study. Blood. 1995. 85:1075–1082.
4. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999. 36:115–127.
5. Meusers P, Hense J, Brittinger G. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia. 1997. 11:Suppl 2. S60–S64.
6. Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003. 97:586–591.
7. Bertoni F, Zucca E, Cotter FE. Molecular basis of mantle cell lymphoma. Br J Haematol. 2004. 124:130–140.
8. Weisenburger DD, Armitage JO. Mantle cell lymphomaan entity comes of age. Blood. 1996. 87:4483–4494.
9. Samaha H, Dumontet C, Ketterer N, Moullet I, Thieblemont C, Bouafia F, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998. 12:1281–1287.
10. Wotherspoon AC, Isaacson PG. Synchronous adenocarcinoma and low grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of the stomach. Histopathology. 1995. 27:325–331.
11. Nakamura S, Aoyagi K, Iwanaga S, Yao T, Tsuneyoshi M, Fujishima M. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients. Cancer. 1997. 79:1077–1085.
12. Ishihama T, Kondo H, Saito D, Yamaguchi H, Shirao K, Yokota T, et al. Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literature. Jpn J Clin Oncol. 1997. 27:101–106.
13. Kanehira K, Braylan RC, Lauwers GY. Early phase of intestinal mantle cell lymphoma: a report of two cases associated with advanced colonic adenocarcinoma. Mod Pathol. 2001. 14:811–817.
14. Padmanabhan V, Trainer TD. Synchronous adenocarcinoma and mantle cell lymphoma of the colon. Arch Pathol Lab Med. 2003. 127:E64–E66.
15. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992. 16:637–640.
16. Lennert K. Feller AC, Diebold J, editors. Centrocytic lymphoma. Histopathology of non-Hodgkin's lymphoma (based on the Kiel classification). 1981. New York, NY: Springer-Verlag;57–62.
17. Berard CW, Dorfman RF. Histopathology of malignant lymphomas. Clin Haematol. 1974. 3:39–79.
18. The Non-Hodgkin's Lymphoma Pathologic Classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982. 49:2112–2135.
19. Tsuchiyama J, Yoshino T, Imajo K, Kondou E, Hamada E, Tomiyama Y, et al. Lymphomatous polyp of mantle cell type in the duodenum complicated by gastric cancer: a case of trisomy 3 and t(11;14)(q13;q32). Ann Hematol. 2002. 81:224–227.
20. Bosch F, López-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998. 82:567–575.
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994. 84:1361–1392.
22. Lee SY, Kim JJ, Lee JH, Kim YH, Rhee PL, Paik SW, et al. Synchronous adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma in a single stomach. Jpn J Clin Oncol. 2005. 35:591–594.
23. Kumar S, Krenacs L, Otsuki T, Kumar D, Harris CA, Wellmann A, et al. bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol. 1996. 105:737–743.
24. Bertoni F, Zucca E, Cotter FE. Molecular basis of mantle cell lymphoma. Br J Haematol. 2004. 124:130–140.
25. Eser B, Kaplan B, Unal A, Canoz O, Altuntas F, Sari HI, et al. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central anatolia, in Turkey. Yonsei Med J. 2006. 47:22–33.
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr